Page last updated: 2024-08-16

propafenone and warfarin

propafenone has been researched along with warfarin in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19902 (12.50)18.7374
1990's0 (0.00)18.2507
2000's10 (62.50)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Kates, RE; Kirsten, EB; Yee, YG1
Brandes, JW; Körst, HA; Littmann, KP1
Khairy, P; Nattel, S1
Wittkowsky, AK1
Bayrakci, B; Karagoz, T; Unal, S; Yasar, U1
Baumert, C; Hilgeroth, A1
Doshchitsin, VL; Kupriianova, OG; Pavlov, AV; Vaniev, SB1
Fauchier, L; Freedman, SB; Gianni, C; Lane, DA; Lip, GY; Natale, A; Nattel, S; Potpara, T; Rienstra, M; Tse, HF; Van Gelder, I1

Reviews

4 review(s) available for propafenone and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
New insights into the mechanisms and management of atrial fibrillation.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2002, Oct-29, Volume: 167, Issue:9

    Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Humans; Practice Guidelines as Topic; Propafenone; Sotalol; Warfarin

2002
Recent advances in the development of P-gp inhibitors.
    Anti-cancer agents in medicinal chemistry, 2009, Volume: 9, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Coumarins; Drug Design; Drug Resistance, Neoplasm; Flavonoids; Humans; Peptides; Propafenone; Propanolamines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Structure-Activity Relationship; Tamoxifen; Terpenes; Verapamil

2009
Atrial fibrillation.
    Nature reviews. Disease primers, 2016, 03-31, Volume: 2

    Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Countershock; Flecainide; Heart Failure; Heart Rate; Humans; Hypertension; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prevalence; Propafenone; Quality of Life; Risk Factors; Sodium Channel Blockers; Stroke; Thromboembolism; Warfarin

2016

Other Studies

12 other study(ies) available for propafenone and warfarin

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Interaction between warfarin and propafenone in healthy volunteer subjects.
    Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:3

    Topics: Adult; Drug Interactions; Humans; Kinetics; Male; Propafenone; Protein Binding; Prothrombin Time; Reference Values; Warfarin

1987
[Beware: propafenon potentiates the effect of oral anticoagulants].
    Medizinische Klinik, 1981, Jun-05, Volume: 76, Issue:12

    Topics: Aged; Anti-Arrhythmia Agents; Anticoagulants; Blood Coagulation Tests; Coumarins; Drug Synergism; Female; Humans; Propafenone; Propiophenones

1981
The "pill-in-the-pocket" approach to atrial fibrillation.
    The New England journal of medicine, 2005, Mar-17, Volume: 352, Issue:11

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Digoxin; Drug Interactions; Humans; Propafenone; Warfarin

2005
Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.
    Clinical drug investigation, 2007, Volume: 27, Issue:7

    Topics: Adolescent; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; Cytochrome P-450 Enzyme System; Digoxin; Drug Overdose; Enzyme Induction; Female; Humans; Hypotension; Plasma Exchange; Propafenone; Rifampin; Warfarin

2007
[Termination of paroxysm of atrial fibrillation conversion using oral propafenone after unsuccessful electrical cardioversion].
    Kardiologiia, 2012, Volume: 52, Issue:4

    Topics: Administration, Oral; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Monitoring; Electric Countershock; Electrocardiography; Humans; Male; Middle Aged; Propafenone; Remission Induction; Treatment Failure; Warfarin

2012